Prospective Memory in Parkinson's Disease

Washington University School of Medicine52 enrolled

Overview

The investigators tested whether prospective memory is impaired in individuals with Parkinson's Disease compared to controls using reliable and validated experimental measures. Also, the investigators assessed the impact of Parkinson's medication on prospective memory performance in PD to better estimate prospective memory function in PD patients' everyday (chronically treated) life.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Memory Prospective Memory Parkinson's Disease

Eligibility

Sex: ALLMin age: 40 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * PD Group: * Clinically definite PD * 40-70 years old * Hoehn and Yahr stage I,II,III * Currently treated with Levodopa/carbidopa * Control Group: * 40-70 years old * Spouses of PD Group preferred Exclusion Criteria: * PD Group and Control Group: * Significant neurological problems * Significant current psychiatric diagnoses * Mini Mental Status Exam score \< 24 (MMSE) * Any significant abnormality on brain imaging * MPTP exposure * Control Participants met the same exclusion criteria described above as well as a biological family history of PD

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States

Outcomes

Primary Outcomes

Virtual Week

Prospective Memory Task; Score range is 0-100%, with higher scores being better performance.

Time frame: One session at baseline.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.